1-3 of 3
Michelle Ridgeway
Close
Sort by
Journal Articles

Identifying Risk Factors for Acute and Chronic Graft-Versus-Host Disease in T-Replete HLA-Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide

Jimena Baron, Michelle Ridgeway, Xu Zhang, PhD, Asad Bashey, MD PhD, Scott R Solomon, MD, H. Kent Holland, MD, Lawrence E Morris, MD, Melhem M Solh, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1977.
https://doi.org/10.1182/blood.V130.Suppl_1.1977.1977
Published: 2017
Journal Articles

Current Graft-Versus-Host Disease (GVHD), Relapse-Free Survival - a Novel, Dynamic Composite Endpoint to Better Define Effectiveness Following Allogenic Hematopoietic Cell Transplantation

Scott R. Solomon, MD, Connie Sizemore, Pharm.D, Michelle Ridgeway, Xu Zhang, PhD, Melhem Solh, MD, Lawrence E. Morris, MD, H. Kent Holland, MD, Asad Bashey, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1170.
https://doi.org/10.1182/blood.V128.22.1170.1170
Published: 2016
Journal Articles

Corticosteroid-Free Primary Treatment of Chronic Graft-Versus-Host Disease with Rituximab Results in Excellent Responses and Rapid Time to Immunosuppression Discontinuation

Connie Sizemore, PharmD, Michelle Ridgeway, RN, OCN, Xu Zhang, PhD, Stacey Brown, B.A., Lawrence E. Morris, MD, Asad Bashey, MD PhD, H. Kent Holland, MD, Scott R. Solomon, MD
Journal: Blood
Blood (2014) 124 (21): 2487.
https://doi.org/10.1182/blood.V124.21.2487.2487
Published: 2014